Publications by authors named "Travis Drow"

Claim this Profile
R
Reduced Function of the Adaptor SH2B3 Promotes T1D via Altered Cytokine-Regulated, T-Cell-Intrinsic Immune Tolerance.
Taylor K Watson, Aaron B I Rosen, Travis Drow, Jacob A Medjo, Matthew A MacQuivey

Diabetes· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced function of the adaptor SH2B3 promotes T1D via altered gc cytokine-regulated, T cell intrinsic immune tolerance.
Taylor K Watson, Aaron B I Rosen, Travis Drow, Jacob A Medjo, Matthew A MacQuivey

bioRxiv· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activated PI3Kδ Specifically Perturbs Mouse Regulatory T Cell Homeostasis and Function Leading to Immune Dysregulation.
Akhilesh K Singh, Fahd Al Qureshah, Travis Drow, Baidong Hou, David J Rawlings

J Immunol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GNTI-122: an autologous antigen-specific engineered Treg cell therapy for type 1 diabetes.
Gene I Uenishi, Marko Repic, Jennifer Y Yam, Ashley Landuyt, Priya Saikumar-Lakshmi, Travis Drow

JCI Insight· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activated PI3Kδ specifically perturbs mouse Treg homeostasis and function leading to immune dysregulation.
Akhilesh K Singh, Fahd Al Qureshah, Travis Drow, Baidong Hou, David J Rawlings

bioRxiv· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A chemically inducible IL-2 receptor signaling complex allows for effective in vitro and in vivo selection of engineered CD4+ T cells.
Peter J Cook, Su Jung Yang, Gene I Uenishi, Annaiz Grimm, Samuel E West, Travis Drow

Mol Ther· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Islet allografts expressing a PD-L1 and IDO fusion protein evade immune rejection and reverse preexisting diabetes in immunocompetent mice without systemic immunosuppression" [American Journal of Transplantation (2022) 2571-2585].
Pradyut K Paul, Rahul Das, Travis Drow, Emily A Nylen, Arnaldo Henrique de Souza

Am J Transplant· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Islet allografts expressing a PD-L1 and IDO fusion protein evade immune rejection and reverse preexisting diabetes in immunocompetent mice without systemic immunosuppression.
Pradyut K Paul, Rahul Das, Travis Drow, Emily A Nylen, Arnaldo Henrique de Souza

Am J Transplant· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancreatic islet-specific engineered T exhibit robust antigen-specific and bystander immune suppression in type 1 diabetes models.
Soo Jung Yang, Akhilesh K Singh, Travis Drow, Tori Tappen, Yuchi Honaker

Sci Transl Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancreatic Stellate Cells Prolong Ex Vivo Islet Viability and Function and Improve Engraftment.
Pradyut K Paul, Rahul Das, Travis J Drow, Arnaldo H de Souza, Appakalai N Balamurugan

Stem Cells Transl Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis